Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 20, 2019 09:15 ET | Source: Reformulary Group

Canada’s first evidence-based medical cannabis formulary launches today

TORONTO, March 20, 2019 (GLOBE NEWSWIRE) -- Reformulary Group, a Canadian healthcare technology company, today announced the launch of Cannabis Standard™ – the first evidence-based medical cannabis...
January 22, 2019 09:00 ET | Source: Reformulary Group

New report: Are prescriptions contributing to the opioid crisis?

TORONTO, Jan. 22, 2019 (GLOBE NEWSWIRE) -- Reformulary Group, a Canadian healthcare technology company, today released a report on opioid prescribing in Canada. The report analyzes the data of over...
September 12, 2018 09:24 ET | Source: Reformulary Group

Starseed joins Cannabis Standard™ for Canadians, employers, physicians

TORONTO, Sept. 12, 2018 (GLOBE NEWSWIRE) -- Reformulary Group, Canada’s leading independent drug plan management company, today announced it has signed Licensed Producer (LP) Starseed Medicinal Inc....
May 29, 2018 14:12 ET | Source: Reformulary Group

Reformulary Group signs Aphria to provide medical cannabis for employer plans

TORONTO, May 29, 2018 (GLOBE NEWSWIRE) -- Reformulary Group, Canada’s leading, independent drug plan management company, today announced it has signed Leamington, Ontario-based cannabis producer...
May 22, 2018 11:40 ET | Source: Reformulary Group

Reformulary Group signs MedReleaf as first Licensed Producer for new medical cannabis formulary

TORONTO, May 22, 2018 (GLOBE NEWSWIRE) -- Reformulary Group, Canada’s leading, independent drug plan management company, today announced it has signed MedReleaf as its first Licensed Producer of...
May 16, 2018 13:22 ET | Source: Reformulary Group

Reformulary Group’s prescription drug tool receives TELUS Outstanding Product Award

TORONTO, May 16, 2018 (GLOBE NEWSWIRE) -- Last night at the 33rd annual Canadian Advanced Technology Alliance Leadership Awards Gala, Reformulary Group received the TELUS Outstanding Product...
May 16, 2018 12:53 ET | Source: Reformulary Group

Expert group to review evidence for use of medical cannabis for employer plans

TORONTO, May 16, 2018 (GLOBE NEWSWIRE) -- Today, Reformulary Group, Canada’s leading, independent drug plan management company, announced its Cannabis Formulary Committee, which will review the best...